ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy.
Publication
, Journal Article
Bainey, KR; Bates, ER; Armstrong, PW
Published in: Circ Cardiovasc Qual Outcomes
June 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Circ Cardiovasc Qual Outcomes
DOI
EISSN
1941-7705
Publication Date
June 2020
Volume
13
Issue
6
Start / End Page
e006834
Location
United States
Related Subject Headings
- Thrombolytic Therapy
- ST Elevation Myocardial Infarction
- SARS-CoV-2
- Pneumonia, Viral
- Percutaneous Coronary Intervention
- Pandemics
- Humans
- Coronavirus Infections
- Cardiovascular System & Hematology
- COVID-19
Citation
APA
Chicago
ICMJE
MLA
NLM
Bainey, K. R., Bates, E. R., & Armstrong, P. W. (2020). ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy. Circ Cardiovasc Qual Outcomes, 13(6), e006834. https://doi.org/10.1161/CIRCOUTCOMES.120.006834
Bainey, Kevin R., Eric R. Bates, and Paul W. Armstrong. “ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy.” Circ Cardiovasc Qual Outcomes 13, no. 6 (June 2020): e006834. https://doi.org/10.1161/CIRCOUTCOMES.120.006834.
Bainey KR, Bates ER, Armstrong PW. ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy. Circ Cardiovasc Qual Outcomes. 2020 Jun;13(6):e006834.
Bainey, Kevin R., et al. “ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy.” Circ Cardiovasc Qual Outcomes, vol. 13, no. 6, June 2020, p. e006834. Pubmed, doi:10.1161/CIRCOUTCOMES.120.006834.
Bainey KR, Bates ER, Armstrong PW. ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy. Circ Cardiovasc Qual Outcomes. 2020 Jun;13(6):e006834.
Published In
Circ Cardiovasc Qual Outcomes
DOI
EISSN
1941-7705
Publication Date
June 2020
Volume
13
Issue
6
Start / End Page
e006834
Location
United States
Related Subject Headings
- Thrombolytic Therapy
- ST Elevation Myocardial Infarction
- SARS-CoV-2
- Pneumonia, Viral
- Percutaneous Coronary Intervention
- Pandemics
- Humans
- Coronavirus Infections
- Cardiovascular System & Hematology
- COVID-19